USA Intravenous (IV) Solution Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.

    Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Intravenous (IV) Solution market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Intravenous (IV) Solution market. Detailed analysis of key players, along with key growth strategies adopted by Intravenous (IV) Solution industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • ICU Medical

    • Fresenius Kabi

    • B Braun Melsungen

    • Baxter

    • Amanta Healthcare

    • Terumo Medical Corporation

    • Grifols

    By Type:

    • by Product Type

    • Total Parenteral Solution

    • Peripheral Parenteral Solution

    • by Nutritional Content

    • Amino Acid Solution

    • Carbohydrates

    • Vitamins & Minerals

    • Parenteral Lipid Emulsion

    • Others

    By End-User:

    • Hospitals & Clinics

    • Ambulatory

    • Homecare

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous (IV) Solution Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Intravenous (IV) Solution Market Size and Growth Rate of by Product Type from 2016 to 2027

      • 1.3.2 USA Intravenous (IV) Solution Market Size and Growth Rate of Total Parenteral Solution from 2016 to 2027

      • 1.3.3 USA Intravenous (IV) Solution Market Size and Growth Rate of Peripheral Parenteral Solution from 2016 to 2027

      • 1.3.4 USA Intravenous (IV) Solution Market Size and Growth Rate of by Nutritional Content from 2016 to 2027

      • 1.3.5 USA Intravenous (IV) Solution Market Size and Growth Rate of Amino Acid Solution from 2016 to 2027

      • 1.3.6 USA Intravenous (IV) Solution Market Size and Growth Rate of Carbohydrates from 2016 to 2027

      • 1.3.7 USA Intravenous (IV) Solution Market Size and Growth Rate of Vitamins & Minerals from 2016 to 2027

      • 1.3.8 USA Intravenous (IV) Solution Market Size and Growth Rate of Parenteral Lipid Emulsion from 2016 to 2027

      • 1.3.9 USA Intravenous (IV) Solution Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Intravenous (IV) Solution Market Size and Growth Rate of Hospitals & Clinics from 2016 to 2027

      • 1.4.2 USA Intravenous (IV) Solution Market Size and Growth Rate of Ambulatory from 2016 to 2027

      • 1.4.3 USA Intravenous (IV) Solution Market Size and Growth Rate of Homecare from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Intravenous (IV) Solution Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous (IV) Solution by Major Types

      • 3.4.1 Market Size and Growth Rate of by Product Type

      • 3.4.2 Market Size and Growth Rate of Total Parenteral Solution

      • 3.4.3 Market Size and Growth Rate of Peripheral Parenteral Solution

      • 3.4.4 Market Size and Growth Rate of by Nutritional Content

      • 3.4.5 Market Size and Growth Rate of Amino Acid Solution

      • 3.4.6 Market Size and Growth Rate of Carbohydrates

      • 3.4.7 Market Size and Growth Rate of Vitamins & Minerals

      • 3.4.8 Market Size and Growth Rate of Parenteral Lipid Emulsion

      • 3.4.9 Market Size and Growth Rate of Others

    4 Segmentation of Intravenous (IV) Solution Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous (IV) Solution by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Intravenous (IV) Solution in Hospitals & Clinics

      • 4.4.2 Market Size and Growth Rate of Intravenous (IV) Solution in Ambulatory

      • 4.4.3 Market Size and Growth Rate of Intravenous (IV) Solution in Homecare

    5 Market Analysis by Regions

    • 5.1 USA Intravenous (IV) Solution Production Analysis by Regions

    • 5.2 USA Intravenous (IV) Solution Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Intravenous (IV) Solution Landscape Analysis

    • 6.1 West USA Intravenous (IV) Solution Landscape Analysis by Major Types

    • 6.2 West USA Intravenous (IV) Solution Landscape Analysis by Major End-Users

    7 South USA Intravenous (IV) Solution Landscape Analysis

    • 7.1 South USA Intravenous (IV) Solution Landscape Analysis by Major Types

    • 7.2 South USA Intravenous (IV) Solution Landscape Analysis by Major End-Users

    8 Middle West USA Intravenous (IV) Solution Landscape Analysis

    • 8.1 Middle West USA Intravenous (IV) Solution Landscape Analysis by Major Types

    • 8.2 Middle West USA Intravenous (IV) Solution Landscape Analysis by Major End-Users

    9 Northeast USA Intravenous (IV) Solution Landscape Analysis

    • 9.1 Northeast USA Intravenous (IV) Solution Landscape Analysis by Major Types

    • 9.2 Northeast USA Intravenous (IV) Solution Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 ICU Medical

        • 10.1.1 ICU Medical Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Fresenius Kabi

        • 10.2.1 Fresenius Kabi Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 B Braun Melsungen

        • 10.3.1 B Braun Melsungen Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Baxter

        • 10.4.1 Baxter Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Amanta Healthcare

        • 10.5.1 Amanta Healthcare Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Terumo Medical Corporation

        • 10.6.1 Terumo Medical Corporation Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Grifols

        • 10.7.1 Grifols Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of by Product Type from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Total Parenteral Solution from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Peripheral Parenteral Solution from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of by Nutritional Content from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Amino Acid Solution from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Carbohydrates from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Vitamins & Minerals from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Parenteral Lipid Emulsion from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Hospitals & Clinics from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Ambulatory from 2016 to 2027

    • Figure USA Intravenous (IV) Solution Market Size and Growth Rate of Homecare from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Intravenous (IV) Solution Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Intravenous (IV) Solution Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Intravenous (IV) Solution

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous (IV) Solution by Different Types from 2016 to 2027

    • Table Consumption Share of Intravenous (IV) Solution by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of by Product Type

    • Figure Market Size and Growth Rate of Total Parenteral Solution

    • Figure Market Size and Growth Rate of Peripheral Parenteral Solution

    • Figure Market Size and Growth Rate of by Nutritional Content

    • Figure Market Size and Growth Rate of Amino Acid Solution

    • Figure Market Size and Growth Rate of Carbohydrates

    • Figure Market Size and Growth Rate of Vitamins & Minerals

    • Figure Market Size and Growth Rate of Parenteral Lipid Emulsion

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Intravenous (IV) Solution by Different End-Users from 2016 to 2027

    • Table Consumption Share of Intravenous (IV) Solution by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals & Clinics

    • Figure Market Size and Growth Rate of Ambulatory

    • Figure Market Size and Growth Rate of Homecare

    • Table USA Intravenous (IV) Solution Production by Regions

    • Table USA Intravenous (IV) Solution Production Share by Regions

    • Figure USA Intravenous (IV) Solution Production Share by Regions in 2016

    • Figure USA Intravenous (IV) Solution Production Share by Regions in 2021

    • Figure USA Intravenous (IV) Solution Production Share by Regions in 2027

    • Table USA Intravenous (IV) Solution Consumption by Regions

    • Table USA Intravenous (IV) Solution Consumption Share by Regions

    • Figure USA Intravenous (IV) Solution Consumption Share by Regions in 2016

    • Figure USA Intravenous (IV) Solution Consumption Share by Regions in 2021

    • Figure USA Intravenous (IV) Solution Consumption Share by Regions in 2027

    • Table West USA Intravenous (IV) Solution Consumption by Types from 2016 to 2027

    • Table West USA Intravenous (IV) Solution Consumption Share by Types from 2016 to 2027

    • Figure West USA Intravenous (IV) Solution Consumption Share by Types in 2016

    • Figure West USA Intravenous (IV) Solution Consumption Share by Types in 2021

    • Figure West USA Intravenous (IV) Solution Consumption Share by Types in 2027

    • Table West USA Intravenous (IV) Solution Consumption by End-Users from 2016 to 2027

    • Table West USA Intravenous (IV) Solution Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Intravenous (IV) Solution Consumption Share by End-Users in 2016

    • Figure West USA Intravenous (IV) Solution Consumption Share by End-Users in 2021

    • Figure West USA Intravenous (IV) Solution Consumption Share by End-Users in 2027

    • Table South USA Intravenous (IV) Solution Consumption by Types from 2016 to 2027

    • Table South USA Intravenous (IV) Solution Consumption Share by Types from 2016 to 2027

    • Figure South USA Intravenous (IV) Solution Consumption Share by Types in 2016

    • Figure South USA Intravenous (IV) Solution Consumption Share by Types in 2021

    • Figure South USA Intravenous (IV) Solution Consumption Share by Types in 2027

    • Table South USA Intravenous (IV) Solution Consumption by End-Users from 2016 to 2027

    • Table South USA Intravenous (IV) Solution Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Intravenous (IV) Solution Consumption Share by End-Users in 2016

    • Figure South USA Intravenous (IV) Solution Consumption Share by End-Users in 2021

    • Figure South USA Intravenous (IV) Solution Consumption Share by End-Users in 2027

    • Table Middle West USA Intravenous (IV) Solution Consumption by Types from 2016 to 2027

    • Table Middle West USA Intravenous (IV) Solution Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Intravenous (IV) Solution Consumption Share by Types in 2016

    • Figure Middle West USA Intravenous (IV) Solution Consumption Share by Types in 2021

    • Figure Middle West USA Intravenous (IV) Solution Consumption Share by Types in 2027

    • Table Middle West USA Intravenous (IV) Solution Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Intravenous (IV) Solution Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Intravenous (IV) Solution Consumption Share by End-Users in 2016

    • Figure Middle West USA Intravenous (IV) Solution Consumption Share by End-Users in 2021

    • Figure Middle West USA Intravenous (IV) Solution Consumption Share by End-Users in 2027

    • Table Northeast USA Intravenous (IV) Solution Consumption by Types from 2016 to 2027

    • Table Northeast USA Intravenous (IV) Solution Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Intravenous (IV) Solution Consumption Share by Types in 2016

    • Figure Northeast USA Intravenous (IV) Solution Consumption Share by Types in 2021

    • Figure Northeast USA Intravenous (IV) Solution Consumption Share by Types in 2027

    • Table Northeast USA Intravenous (IV) Solution Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Intravenous (IV) Solution Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Intravenous (IV) Solution Consumption Share by End-Users in 2016

    • Figure Northeast USA Intravenous (IV) Solution Consumption Share by End-Users in 2021

    • Figure Northeast USA Intravenous (IV) Solution Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of ICU Medical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ICU Medical

    • Figure Sales and Growth Rate Analysis of ICU Medical

    • Figure Revenue and Market Share Analysis of ICU Medical

    • Table Product and Service Introduction of ICU Medical

    • Table Company Profile and Development Status of Fresenius Kabi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius Kabi

    • Figure Sales and Growth Rate Analysis of Fresenius Kabi

    • Figure Revenue and Market Share Analysis of Fresenius Kabi

    • Table Product and Service Introduction of Fresenius Kabi

    • Table Company Profile and Development Status of B Braun Melsungen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of B Braun Melsungen

    • Figure Sales and Growth Rate Analysis of B Braun Melsungen

    • Figure Revenue and Market Share Analysis of B Braun Melsungen

    • Table Product and Service Introduction of B Braun Melsungen

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of Amanta Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amanta Healthcare

    • Figure Sales and Growth Rate Analysis of Amanta Healthcare

    • Figure Revenue and Market Share Analysis of Amanta Healthcare

    • Table Product and Service Introduction of Amanta Healthcare

    • Table Company Profile and Development Status of Terumo Medical Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Terumo Medical Corporation

    • Figure Sales and Growth Rate Analysis of Terumo Medical Corporation

    • Figure Revenue and Market Share Analysis of Terumo Medical Corporation

    • Table Product and Service Introduction of Terumo Medical Corporation

    • Table Company Profile and Development Status of Grifols

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

    • Figure Sales and Growth Rate Analysis of Grifols

    • Figure Revenue and Market Share Analysis of Grifols

    • Table Product and Service Introduction of Grifols


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.